Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory...

por Lees, Charlie W., Regueiro, Miguel, Mahadevan, Uma
Publicado 2020

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply

por Alexander, James L, Kennedy, Nicholas A, Lees, Charlie W, Ahmad, Tariq, Powell, Nick
Publicado 2021

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease

por Kennedy, Nicholas A., Jones, Gareth-Rhys, Plevris, Nikolas, Patenden, Rebecca, Arnott, Ian D., Lees, Charlie W.
Publicado 2019

Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program

por Chiorean, Michael, Daperno, Marco, Lees, Charlie W., Bonfanti, Gianluca, Soudis, Dimitrios, Modesto, Irene, Deuring, J. Jasper, Edwards, Roger A.
Publicado 2023

Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies

por Lees, Charlie W., Deuring, J. Jasper, Chiorean, Michael, Daperno, Marco, Bonfanti, Gianluca, Germino, Rebecca, Brown, Pritha Bhadra, Modesto, Irene, Edwards, Roger A.
Publicado 2021

Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort

por Gros, Beatriz, Plevris, Nikolas, Constantine‐Cooke, Nathan, Lyons, Mathew, O'Hare, Claire, Noble, Colin, Arnott, Ian D., Jones, Gareth‐Rhys, Lees, Charlie W., Derikx, Lauranne A. A. P.
Publicado 2023

Clinical Utility And Diagnostic Accuracy of Faecal Calprotectin For IBD At First Presentation To Gastroenterology Services In Adults Aged 16–50 Years

por Kennedy, Nicholas A., Clark, Annalie, Walkden, Andrew, Chang, Jeff C.W., Fascí-Spurio, Federica, Muscat, Martina, Gordon, Brydon W., Kingstone, Kathleen, Satsangi, Jack, Arnott, Ian D.R., Lees, Charlie W.
Publicado 2015

The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease

por Kennedy, Nicholas A, Lamb, Christopher A, Berry, Susan H, Walker, Alan W, Mansfield, John, Parkes, Miles, Simpkins, Rachel, Tremelling, Mark, Nutland, Sarah, Parkhill, Julian, Probert, Chris, Hold, Georgina L, Lees, Charlie W
Publicado 2018

The Impact of Different DNA Extraction Kits and Laboratories upon the Assessment of Human Gut Microbiota Composition by 16S rRNA Gene Sequencing

por Kennedy, Nicholas A., Walker, Alan W., Berry, Susan H., Duncan, Sylvia H., Farquarson, Freda M., Louis, Petra, Thomson, John M., Satsangi, Jack, Flint, Harry J., Parkhill, Julian, Lees, Charlie W., Hold, Georgina L.
Publicado 2014

The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn’s Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation

por Nelson, Andrew, Stewart, Christopher J, Kennedy, Nicholas A, Lodge, John K, Tremelling, Mark, Probert, Chris S, Parkes, Miles, Mansfield, John C, Smith, Darren L, Hold, Georgina L, Lees, Charlie W, Bridge, Simon H, Lamb, Christopher A
Publicado 2020

IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology

por Jones, Gareth-Rhys, Lyons, Mathew, Plevris, Nikolas, Jenkinson, Philip W, Bisset, Cathy, Burgess, Christopher, Din, Shahida, Fulforth, James, Henderson, Paul, Ho, Gwo-Tzer, Kirkwood, Kathryn, Noble, Colin, Shand, Alan G, Wilson, David C, Arnott, Ian DR, Lees, Charlie W
Publicado 2019

Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis

por Lyons, Mathew, Derikx, Lauranne A. A. P., Fulforth, James, McCall, Sophie, Plevris, Nikolas, Jenkinson, Philip W., Kirkwood, Kathryn, Siakavellas, Spyros, Lucaciu, Laura, Constantine‐Cooke, Nathan, Arnott, Ian D., Henderson, Paul, Russell, Richard K., Wilson, David C., Lees, Charlie W., Jones, Gareth‐Rhys
Publicado 2022

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational...

por Derikx, Lauranne A A P, Dolby, Heather W, Plevris, Nikolas, Lucaciu, Laura, Rees, Caitlin S, Lyons, Mathew, Siakavellas, Spyros I, Constantine-Cooke, Nathan, Jenkinson, Philip, Su, Shanna, O’Hare, Claire, Kirckpatrick, Laura, Merchant, Lynne M, Noble, Colin, Arnott, Ian D, Jones, Gareth-Rhys, Lees, Charlie W
Publicado 2021

Analysis of Germline GLI1 Variation Implicates Hedgehog Signalling in the Regulation of Intestinal Inflammatory Pathways

por Lees, Charlie W, Zacharias, William J, Tremelling, Mark, Noble, Colin L, Nimmo, Elaine R, Tenesa, Albert, Cornelius, Jennine, Torkvist, Leif, Kao, John, Farrington, Susan, Drummond, Hazel E, Ho, Gwo-Tzer, Arnott, Ian D. R, Appelman, Henry D, Diehl, Lauri, Campbell, Harry, Dunlop, Malcolm G, Parkes, Miles, Howie, Sarah E. M, Gumucio, Deborah L, Satsangi, Jack
Publicado 2008

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab...

por Liu, Zhigang, Le, Kaixing, Zhou, Xin, Alexander, James L, Lin, Simeng, Bewshea, Claire, Chanchlani, Neil, Nice, Rachel, McDonald, Timothy J, Lamb, Christopher A, Sebastian, Shaji, Kok, Klaartje, Lees, Charlie W, Hart, Ailsa L, Pollok, Richard C, Boyton, Rosemary J, Altmann, Daniel M, Pollock, Katrina M, Goodhand, James R, Kennedy, Nicholas A, Ahmad, Tariq, Powell, Nick
Publicado 2023

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group positi...

por Alexander, James L, Moran, Gordon W, Gaya, Daniel R, Raine, Tim, Hart, Ailsa, Kennedy, Nicholas A, Lindsay, James O, MacDonald, Jonathan, Segal, Jonathan P, Sebastian, Shaji, Selinger, Christian P, Parkes, Miles, Smith, Philip J, Dhar, Anjan, Subramanian, Sreedhar, Arasaradnam, Ramesh, Lamb, Christopher A, Ahmad, Tariq, Lees, Charlie W, Dobson, Liz, Wakeman, Ruth, Iqbal, Tariq H, Arnott, Ian, Powell, Nick
Publicado 2021

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

por Chanchlani, Neil, Lin, Simeng, Chee, Desmond, Hamilton, Benjamin, Nice, Rachel, Arkir, Zehra, Bewshea, Claire, Cipriano, Bessie, Derikx, Lauranne A A P, Dunlop, Allan, Greathead, Louise, Griffiths, Rachel L, Ibraheim, Hajir, Kelleher, Peter, Kok, Klaartje B, Lees, Charlie W, MacDonald, Jonathan, Sebastian, Shaji, Smith, Philip J, McDonald, Timothy J, Irving, Peter M, Powell, Nick, Kennedy, Nicholas A, Goodhand, James R, Ahmad, Tariq
Publicado 2021

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB

por Alexander, James L., Kennedy, Nick, Ibraheim, Hajir, Anandabaskaran, Sulak, Saifuddin, Aamir, Seoane, Rocio Castro, Liu, Zhigang, Nice, Rachel, Bewshea, Claire M., D'Mello, Andrea, Constable, Laura E., Jones, Gareth-Rhys, Balarajah, Sharmili, Fiorentino, Francesca, Sebastian, Shaji, Irving, Peter M., Hicks, Lucy C., Williams, Horace R., Kent, Alexandra J., Parkes, Miles, Kok, Klaartje, Patel, Kamal V, Altmann, Daniel, Boyton, Rosemary, Goodhand, James, Hart, Ailsa, Lees, Charlie W., Ahmad, Tariq, Powell, Nick
Publicado 2022

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

por Alexander, James L., Mullish, Benjamin H., Danckert, Nathan P., Liu, Zhigang, Olbei, Marton L., Saifuddin, Aamir, Torkizadeh, Melissa, Ibraheim, Hajir, Blanco, Jesús Miguéns, Roberts, Lauren A., Bewshea, Claire M., Nice, Rachel, Lin, Simeng, Prabhudev, Hemanth, Sands, Caroline, Horneffer-van der Sluis, Verena, Lewis, Matthew, Sebastian, Shaji, Lees, Charlie W., Teare, Julian P., Hart, Ailsa, Goodhand, James R., Kennedy, Nicholas A., Korcsmaros, Tamas, Marchesi, Julian R., Ahmad, Tariq, Powell, Nick
Publicado 2023

Exploring the genetic architecture of inflammatory bowel disease by whole genome sequencing identifies association at ADCY7

por Luo, Yang, de Lange, Katrina M., Jostins, Luke, Moutsianas, Loukas, Randall, Joshua, Kennedy, Nicholas A., Lamb, Christopher A., McCarthy, Shane, Ahmad, Tariq, Edwards, Cathryn, Serra, Eva Goncalves, Hart, Ailsa, Hawkey, Chris, Mansfield, John C., Mowat, Craig, Newman, William G., Nichols, Sam, Pollard, Martin, Satsangi, Jack, Simmons, Alison, Tremelling, Mark, Uhlig, Holm, Wilson, David C., Lee, James C., Prescott, Natalie J., Lees, Charlie W., Mathew, Christopher G., Parkes, Miles, Barrett, Jeffrey C., Anderson, Carl A.
Publicado 2017